Skip to content
Delayed ~15 min

RGNX REGENXBIO

Health Care · Russell 2000

Next earnings: not announced yet

What 16 analyst firms say about REGENXBIO: their latest ratings, price targets and how far the stock is from them. How it works

7.62 USD+0.24 (+3.25%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+232.8%to the avg target 25.36 USD+17.74 USD
Buy 14 · Hold 4 · Sell 0

18 rated views · 19 analyst/firm records · 16 firms

Latest report28 Sep 2026avg report date 23 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8057
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8048

Recent analyst activity · last 90 days

Our tracked history has 9 reports on RGNX from 7 analyst firms in the last 90 days (16 firms in the past year).

Comparing each firm's latest target with its previous one: 1 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: HC Wainwright lowered its target from $23.00 (set 10 Aug 2026) to $21.00 on 25 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdBrian SkorneyBuy25 Aug 202629.00 USD
Bank of America SecuritiesGeoff MeachamBuy15 May 202614.00 USD
BarclaysEliana MerleHold7 Aug 202612.00 USD
BarclaysGena WangHold7 Aug 2026—
Chardan Capital MarketsDaniil GataulinBuy15 Jul 202650.00 USD
Chardan Capital MarketsKeay T NakaeBuy20 Jun 202650.00 USD
Clear Street LLCKaveri PohlmanBuy24 Aug 202632.00 USD
Goldman SachsPaul K ChoiHold21 May 202610.00 USD
H.C. WainwrightYi ChenBuy28 Sep 202621.00 USD
Leerink PartnersLili NsongoBuy6 Jul 202619.00 USD
Leerink PartnersMani ForooharBuy22 Jun 202618.00 USD
MizuhoGraig SuvannavejhBuy5 Oct 2026Conflicting reports · excluded
Morgan StanleyUnnamed analystBuy7 Aug 202618.00 USD
Raymond JamesSean MccutcheonBuy24 Aug 2026—
RBC Capital MarketsLuca IssiBuy7 Aug 202619.00 USD
StifelAnnabel SamimyBuy19 Dec 202545.00 USD
UBSUnnamed analystBuy10 Feb 202618.00 USD
Weiss RatingsUnnamed analyst—4 Sep 2026—
Data feed RESEARCHResearch TeamHold12 Aug 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:52 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.